Int J Med Rev 2020 April;7(2): 47-49

10.30491/ijmr.2020.229939.1101

Copyright © 2020 The Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://

creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly

cited.

INTERNATIONAL JOURNAL OF

MEDICAL

REVIEWS

Mini Review

Ocular Problems Associated with Coronavirus Disease 2019

Krisnhaliani Wetarini1

1 Department of Medicine, Bhayangkara Denpasar Hospital/Faculty of Medicine, Udayana University, Denpasar, Bali, Indonesia

Corresponding Author: Krisnhaliani Wetarini, Department of Medicine, Bhayangkara Denpasar Hospital/Faculty of Medicine,

Udayana University, Serma Made Pil St. 8B, Denpasar, Bali, Indonesia, Postcode 80114. Tel: +62 82144046666, Email:

krisnhaliani@yahoo.com

Received May 05, 2020; Accepted May 09, 2020; Online Published June 30, 2020

Abstract

Coronavirus disease 2019 has become a worldwide pandemic caused by the infection of severe acute respiratory syndrome coronavirus 2. The

infection of this viral illness may cause several ocular manifestations, such as conjunctival congestion, epiphora, and foreign body sensation.

Conjunctival mucosa is thought to be one of the certain mediums of transmission of the disease due to the presence of angiotensin-converting

enzyme 2, which acts as an intermediary for the invasion of viruses into host cells. Some recommendations have been made to prevent the

spreading of the disease in the course of ophthalmic practices. This review aims to emphasize the ocular problems associated with novel

coronavirus disease and lays out the efforts that can be done related to disease prevention.

Keywords: Novel Coronavirus, Severe Acute Respiratory Syndrome, Angiotensin-converting Enzyme, Ophthalmology, Infection

Wetarini

48 | International Journal of Medical Reviews. 2020;7(2):47-49

Ocular Problems Associated with Coronavirus Disease 2019

International Journal of Medical Reviews. 2020;7(2):47-49 | 49

1. World Health Organization. Coronavirus (COVID-19) [Internet].

2020. Available from: https://covid19.who.int. Accessed on April

29, 2020.

2. World Health Organization. WHO announces COVID-19

outbreak a pandemic [Internet]. 2020. Available from:

http://www.euro.who.int/en/health-topics/health-

emergencies/ coronavirus-covid-19/news/news/2020/3/who-

announces-covid-19-outbreak-a-pandemic. Accessed on April

29, 2020.

3. Yuki K, Fujiogi M, Koutsogiannaki S. COVID-19 pathophysiology:

A review. Clin Immunol. 2020;108427.

doi:10.1016/j.clim.2020.108427

4. Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. Genomic

characterisation and epidemiology of 2019 novel coronavirus:

implications for virus origins and receptor binding. Lancet.

2020;395(10224):565-574. doi:10.1016/S0140-6736(20)30251-8

5. Huang C, Wang Y, Li X, et al. Clinical features of patients infected

with 2019 novel coronavirus in Wuhan, China. Lancet.

2020;395(10223):497-506. doi:10.1016/S0140-6736(20)30183-5

6. Ping W, Duan F, Luo C, Liu Q, Qu X, Liang L, et al. Characteristic

of ocular findings of patients with coronavirus disease 2019

(COVID-19) in Hubei Province, China. JAMA Ophthalmology.

2020;E1-E4. doi:10.1001/jamaophthalmol.2020.1291

7. Chen L, Deng C, Chen X, Zhang X, Chen B, Yu H, et al. Ocular

manifestation and clinical characteristic of 534 cases of COVID-

19 in China: a cross-sectional study. medRxiv; 2020.

doi:10.1101/2020.03.12.20034678

8. Chen L, Liu M, Zhang Z, Qiao K, Huang T, Chen M, Xin N, Huang

Z, Liu L, Zhang G, Wang J. Ocular manifestations of a

hospitalised patient with confirmed 2019 novel coronavirus

disease. British Journal of Ophthalmology. 2020;104(6):748-51.

doi:10.1136/bjophthalmol-2020-316304

9. Peiris JS, Yuen KY, Osterhaus AD, Stöhr K. The severe acute

respiratory syndrome. New England Journal of Medicine. 2003

Dec 18;349(25):2431-41. doi:10.1056/NEJMra032498

10. Loon SC, Teoh SC, Oon LL, Se-Thoe SY, Ling AE, Leo YS, Leong

HN. The severe acute respiratory syndrome coronavirus in tears.

British journal of ophthalmology. 2004;88(7):861-3.

doi:10.1136/bjo.2003.035931

11. Su S, Wong G, Shi W, Liu J, Lai AC, Zhou J, Liu W, Bi Y, Gao GF.

Epidemiology, genetic recombination, and pathogenesis of

coronaviruses. Trends in microbiology. 2016;24(6):490-502.

doi:10.1016/j.tim.2016.03.003

12. World Health Organization. Report of the WHO-China joint

mission on coronavirus diseases 2019 (COVID-19). 2020.

13. Hong N, Yu W, Xia J, Shen Y, Yap M, Han W. Are ocular

symptoms common in patients with COVID-19? [Pre-print].

Lancet Glob Health. 2020. doi:10.1111/aos.14445

14. Seah I, Agrawal R. Can the coronavirus disease 2019 (COVID-19)

affect the eyes? A review of coronaviruses and ocular

implications in humans and animals. Ocular immunology and

inflammation. 2020;28(3):391-5.

doi:10.1080/09273948.2020.1738501

15. American Academy of Ophthalmology. Important coronavirus

updates for ophthalmologists [Internet]. 2020. Available from:

https://www.aao.org/headline/alert-important-coronavirus-

context. Accessed on May 1, 2020.

16. Sun Y, Liu L, Pan X, Jing M. Mechanism of the action between

the SARS-CoV S240 protein and the ACE2 receptor in eyes. Int J

Ophthalmol. 2006;6(4):783-6.

17. Jun IS, Anderson DE, Kang AE, Wang LF, Rao P, Young BE, Lye

DC, Agrawal R. Assessing viral shedding and infectivity of tears

in coronavirus disease 2019 (COVID-19) patients.

Ophthalmology. 2020. doi:10.1016/j.ophtha.2020.03.026

18. Xia J, Tong J, Liu M, Shen Y, Guo D. Evaluation of coronavirus in

tears and conjunctival secretions of patients with SARS‐CoV‐2

infection. Journal of medical virology. 2020;92(6):589-94.

doi:10.1002/jmv.25725

19. World Health Organization. Coronavirus disease 2019 (COVID-

19) situation report- 82. 2020.

20. Sun CB, Wang YY, Liu GH, Liu Z. Role of the eye in transmitting

human coronavirus: what we know and what we do not know.

Frontiers in Public Health. 2020;8:155.

doi:10.3389/fpubh.2020.00155